Adjuvant Global Health Technology Fund, L.P. - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 14, 2023, Adjuvant Global Health Technology Fund, L.P.'s relationship to AN2 Therapeutics, Inc. (ANTX) is TenPercentOwner, and currently has 2,080,051 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ANTX insiders.
Data Source: SEC.
Adjuvant Global Health Technology Fund, L.P. - Insider Non-Derivative Transactions of ANTX Common Stock
Adjuvant Global Health Technology Fund, L.P. - Insider Non-Derivative Transactions at ANTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 15, 2023 | Sell -- (Common Stock) | 288 | 16.15 | 393449 |
| Nov 15, 2023 | Sell -- (Common Stock) | 1522 | 16.15 | 2080051 |
| Sep 29, 2023 | Sell -- (Common Stock) | 1356 | 16.11 | 410403 |
| Sep 29, 2023 | Sell -- (Common Stock) | 7160 | 16.11 | 2169680 |
| Sep 28, 2023 | Sell -- (Common Stock) | 134 | 16.07 | 411759 |
| Sep 28, 2023 | Sell -- (Common Stock) | 707 | 16.07 | 2176840 |
| Sep 8, 2023 | Sell -- (Common Stock) | 537 | 16.05 | 411957 |
| Sep 8, 2023 | Sell -- (Common Stock) | 2841 | 16.05 | 2177883 |
| Sep 7, 2023 | Sell -- (Common Stock) | 598 | 16.02 | 412494 |
| Sep 7, 2023 | Sell -- (Common Stock) | 3164 | 16.02 | 2180724 |